The PIP scandal: An analysis of the process of quality control that failed to safeguard women from the health risks

Journal of the Royal Society of Medicine

Volumn 106, Issue 5, 2013, Pages 173-177

  Martindale, Victoria ^a   Menache, Andre ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; PLATINUM; SILICONE GEL;

ARTICLE; BREAST IMPLANT; DEVICE SAFETY; HEALTH HAZARD; HUMAN; PLASTIC SURGEON; QUALITY CONTROL; SILICONE PROSTHESIS; WOMEN'S HEALTH; BREAST AUGMENTATION; FEMALE; LEGAL ASPECT; PATIENT SAFETY; STANDARD; UNITED KINGDOM;

BREAST IMPLANTATION; BREAST IMPLANTS; FEMALE; GREAT BRITAIN; HUMANS; PATIENT SAFETY; QUALITY CONTROL;

EID: 84882249606     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1177/0141076813480994     Document Type: Article

References (20)

1. See http://www.guardian.co.uk/news/datablog/2012/jan/30/plastic-surgery-statistics-uk (last accessed 13 April 2013)
2. See http://www.nhs.uk/Conditions/Breast-implants/Pages/Regulation-and-safety.aspx (last accessed 13 April 2013)
3. See http://www.nhs.uk/conditions/breast-implants/documents/PIP%20expert%20group%20final%20report.pdf (last accessed 13 April 2013)
4. See http://www.mhra.gov.uk/home/groups/comms-ic/documents/websiteresources/con216972.pdf (last accessed 13 April 2013)
5. Williams D. Silicon, silicone and silica: the importance of the right ending. Med Device Technol 1996;7:7-11
6. See http://europa.eu/rapid/press-release_IP-12-96_en.htm (last accessed 13 April 2013)
7. Maharaj SV. Platinum concentration in silicone breast implant material and capsular tissue by ICP-MS. Anal Bioanal Chem 2004;380:84-9
8. See http://www.tga.gov.au/safety/alerts-device-breastimplants-pip-120402.htm (last accessed 13 April 2013)
9. See http://ec.europa.eu/environment/endocrine/documents/final_report_2007.pdf (last accessed 15 August 2012)
10. Calafat AM, Weuve J, Ye X, et al. Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants. Environ Health Perspect 2009;117:639-44
11. Ikezuki Y, Tsutsumi O, Takai Y, Kamei Y, Taketani Y. Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum Reprod 2002;17:2839-41
12. Schonfelder G, Wittfoht W, Hopp H, Talsness CE, Paul M, Chahoud I. Parent Bisphenol A accumulation in the human maternal-fetal-placental unit. Environ Health Perspect 2002;110:A703-A707
13. Cantonwine D, Meeker JD, Hu H, et al. Bisphenol A exposure in Mexico City and risk of prematurity: a pilot nested case control study. Environ Health 2010;18:62
14. Le HH, Carlson EM, Chua JP, Belcher SM. Bisphenol A is released from polycarbonate drinking bottles and mimics the neurotoxic actions of estrogen in developing cerebellar neurons. Toxicol Lett 2008;176:149-56
15. Sahu SC. Toxicogenomics: A Powerful Tool for Toxicity Assessment. Chichester: John Wiley & Sons, 2008
16. Boverhof DR, Gollapudi B, eds. Applications of Toxicogenomics in Safety Evaluation and Risk Assessment. Hoboken, NJ: John Wiley & Sons, 2011
17. See http://www.guardian.co.uk/world/2012/jan/06/medical-devices-toys-safety-checks (last accessed 13 April 2013)
18. See http://www.nibsc.ac.uk/science/biotherapeutics/therapeutic_toxins_-_botulinum.aspx (last accessed 13 April 2013)
19. Holmich LR, Fryzek JP, Kjøller K, et al. The diagnosis of silicone breast-implant rupture: clinical findings comparedwith findings at magnetic resonance imaging. Ann Plast Surg 2005;54:583-9
20. Brown SL, Middleton MS, Berg WA, Soo MS, Pennello G. Prevalence of rupture of silicone gel breast implants revealed on MR imaging in a population of women in Birmingham, Alabama. AJR Am J Roentgenol 2000;175:1057-64